These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1315397)

  • 1. Clinical aspects of kala-azar in children from the Sudan: a comparison with the disease in adults.
    Zijlstra EE; Ali MS; el-Hassan AM; el-Toum IA; Satti M; Ghalib HW
    J Trop Pediatr; 1992 Feb; 38(1):17-21. PubMed ID: 1315397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kala-azar in displaced people from southern Sudan: epidemiological, clinical and therapeutic findings.
    Zijlstra EE; Ali MS; el-Hassan AM; el-Toum IA; Satti M; Ghalib HW; Sondorp E; Winkler A
    Trans R Soc Trop Med Hyg; 1991; 85(3):365-9. PubMed ID: 1658990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis.
    Zijlstra EE; Khalil EA; Kager PA; El-Hassan AM
    Br J Dermatol; 2000 Jul; 143(1):136-43. PubMed ID: 10886148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and laboratory study of kala-azar in children in Nepal.
    Singh K; Singh R; Parija SC; Faridi MM; Bhatta N
    J Trop Pediatr; 1999 Apr; 45(2):95-7. PubMed ID: 10341503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of kala-azar in the Sudan with sodium stibogluconate: a randomized trial of three dosage regimens.
    Zijlstra EE; Siddig Ali M; el-Hassan AM; Hofland HW; el-Toum I; Satti M; Ghalib HW
    Trans R Soc Trop Med Hyg; 1993; 87(3):307-9. PubMed ID: 8236402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis).
    Thakur CP
    Trans R Soc Trop Med Hyg; 1984; 78(3):391-8. PubMed ID: 6087515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conflict and kala-azar: determinants of adverse outcomes of kala-azar among patients in southern Sudan.
    Collin S; Davidson R; Ritmeijer K; Keus K; Melaku Y; Kipngetich S; Davies C
    Clin Infect Dis; 2004 Mar; 38(5):612-9. PubMed ID: 14986243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium stibogluconate and paromomycin for treating visceral leishmaniasis under routine conditions in eastern Sudan.
    Atia AM; Mumina A; Tayler-Smith K; Boulle P; Alcoba G; Elhag MS; Alnour M; Shah S; Chappuis F; van Griensven J; Zachariah R
    Trop Med Int Health; 2015 Dec; 20(12):1674-84. PubMed ID: 26427033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of prolonged therapy with stibogluconate in post kala-azar dermal leishmaniasis.
    Thakur CP; Kumar K
    Indian J Med Res; 1990 Mar; 91():144-8. PubMed ID: 2160914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of treatment regimens of kala-azar based on culture & sensitivity of amastigotes to sodium antimony gluconate.
    Thakur CP; Thakur S; Narayan S; Sinha A
    Indian J Med Res; 2008 Jun; 127(6):582-8. PubMed ID: 18765878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Visceral leishmaniasis (kala-azar). A rare differential diagnosis of splenomegaly and pancytopenia].
    Baldus M; Schleiffer T; Brass H
    Dtsch Med Wochenschr; 1989 Dec; 114(48):1876-81. PubMed ID: 2555125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroepidemiological study on kala-azar in Baringo District, Kenya.
    Jahn A; Lelmett JM; Diesfeld HJ
    J Trop Med Hyg; 1986 Apr; 89(2):91-104. PubMed ID: 3021967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum erythropoietin concentration in anaemia of visceral leishmaniasis (kala-azar) before and during antimonial therapy.
    Saeed AM; Khalil EA; Elhassan AM; Hashim FA; Elhassan AM; Fandrey J; Jelkmann W
    Br J Haematol; 1998 Mar; 100(4):720-4. PubMed ID: 9531339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The response of Kenyan kala-azar to treatment with sodium stibogluconate.
    Rees PH; Kager PA; Wellde BT; Hockmeyer WT
    Am J Trop Med Hyg; 1984 May; 33(3):357-61. PubMed ID: 6329010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A thirty day course of sodium stibogluconate for treatment of Kala-azar in Nepal.
    Karki P; Koirala S; Parija SC; Hansdak SG; Das ML
    Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):154-8. PubMed ID: 9740292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kala-azar in a four-year-old child 18 months after brief exposure in Malta.
    Ornvold K; Carstensen H; Magnussen P; Nielsen MH; Pedersen FK
    Acta Paediatr Scand; 1989 Jul; 78(4):650-2. PubMed ID: 2551125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observations on the effect of verapamil with sodium stibogluconate in kala azar.
    Thakur CP; Kumar M
    Trop Geogr Med; 1992 Jan; 44(1-2):15-8. PubMed ID: 1323160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicoepidemiological profile of kala azar patients in Delhi.
    Mittal V; Bhatia R; Sehgal S
    J Commun Dis; 1989 Dec; 21(4):255-61. PubMed ID: 2638373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of kala-azar in southern Sudan using a 17-day regimen of sodium stibogluconate combined with paromomycin: a retrospective comparison with 30-day sodium stibogluconate monotherapy.
    Melaku Y; Collin SM; Keus K; Gatluak F; Ritmeijer K; Davidson RN
    Am J Trop Med Hyg; 2007 Jul; 77(1):89-94. PubMed ID: 17620635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal amphotericin B for complicated visceral leishmaniasis (kala-azar) in eastern Sudan: how effective is treatment for this neglected disease?
    Salih NA; van Griensven J; Chappuis F; Antierens A; Mumina A; Hammam O; Boulle P; Alirol E; Alnour M; Elhag MS; Manzi M; Kizito W; Zachariah R
    Trop Med Int Health; 2014 Feb; 19(2):146-52. PubMed ID: 24433217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.